EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF



Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF



Human Immunology 68(5): 368-374



Administration of recombinant-human G-CSF (rhG-CSF) is highly efficient in mobilizing hematopoietic stem and progenitor cells (HSC/HPC) from the bone marrow (BM) toward the peripheral blood. This study was designed to investigate whether repeated G-CSF-induced HSC/HPC mobilization in mice could lead to a depletion of the bone marrow HSC/HPC pool with subsequent loss of mobilizing capacity. To test this hypothesis Balb/c mice were treated with a maximum of 12 repeated 5-day cycles of either 10 microg rhG-CSF/day or 0.25 microg rmG-CSF/day. Repeated administration of rhG-CSF lead to strong inhibition of HSC/HPC mobilization toward the peripheral blood and spleen after >4 cycles because of the induction of anti-rhG-CSF antibodies. In contrast, after repeated administration of rmG-CSF, HSC/HPC mobilizing capacity remained intact for up to 12 cycles. The number of CFU-GM per femur did not significantly change for up to 12 cycles. We conclude that repeated administration of G-CSF does not lead to depletion of the bone marrow HSC/HPC pool.

(PDF emailed within 0-6 h: $19.90)

Accession: 013811647

Download citation: RISBibTeXText

PMID: 17462504

DOI: 10.1016/j.humimm.2007.01.017



Related references

Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization. Bmb Reports 50(3): 138-143, 2016

Bone marrow stem/progenitor cell mobilization in C57BL/6J and BALB/c mice. Laboratory Animal Research 30(1): 14-20, 2014

Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor and recombinant human granulocyte colony-stimulating factor. Experimental Hematology (Charlottesville) 23(11): 1180-1186, 1995

Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Experimental Hematology 23(11): 1180-1186, 1995

Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?. Stem Cells 26(5): 1211-1220, 2008

Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 81(7): 1960-1967, 1993

Overlapping roles for endothelial selectins in murine hematopoietic stem/progenitor cell homing to bone marrow. Experimental Hematology 41(7): 588-596, 2013

Oral administration of insulin receptor-interacting lectins leads to an enhancement in the hematopoietic stem and progenitor cell pool of mice. Stem Cells and Development 19(2): 163-174, 2010

Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice. International Journal of Hematology 97(1): 50-57, 2013

Hematopoietic stem and progenitor cell mobilization in mice. Methods in Molecular Biology 1185: 43-64, 2015

In vitro expansion of murine hematopoietic progenitor cells in liquid cultures for bone marrow transplantation: effects of stem cell factor. International Journal of Hematology 57(2): 113-120, 1993

Mobilization studies in mice deficient in either C3 or C3a receptor reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow Implications for the use of the C3aR antagonist as a new mobilization-facilitating agent. Blood 102(11): 114a, November 16, 2003

Human blood contains inducible progenitor cell-chemotactic activity Implications for progenitor cell recirculation in the course of bone marrow transplantation and progenitor cell mobilization. Annals of Hematology 77(SUPPL 2): S213, 1998

Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. Journal of Experimental Medicine 208(2): 261-271, 2011

The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization. Biology of Blood and Marrow Transplantation 14(6): 603-621, 2008